France Flow Cytometry Market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Access Full Report: https://databridgemarketresearch.com/reports/france-flow-cytometry-market
The France flow cytometry market is highly concentrated to a few big players and rest to local players catering to the domestic markets only. BD dominated the flow cytometry market accounting for a highest market share in 2017, followed by Merck KGaA, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, bioMérieux SA and other players in this markets are ACEA BIO, Apogee Flow Systems Ltd, Beckman Coulter, Inc, Enzo Life Sciences, Inc, Luminex Corporation, Mechatronics, Miltenyi Biotec, Sony Biotechnology Inc, Stratedigm, Inc, Sysmex Partec GmbH (A subsidary of Sysmex Corporation), Takara Bio Inc, among others.
BD.:
BD was founded in 1897, and is located at New Jersey, U.S., BD engaged with the development, manufacture of medical devices, laboratory equipments, diagnostic healthcare for pharmaceutical company, clinical laboratories and others. The company operates its business through BD Medical, BD Life Sciences. The flow cytometry products are available under the BD Life Sciences. The company has it presence in United States, Europe, Greater Asia and others.
- In April 2018, BD (U.S.) announced the launch of the BD FACSymphony S6 cell sorter, which will be on display at the 33rd Congress of the International Society for Advancement of Cytometry next week in Prague. The new platform leverages the high parameter capabilities of the BD FACSymphony cell analyzer, giving researchers the ability to sort cell populations for better understanding of cell phenotypes for immunology and multi-omics research. This product launch has expanded their product line.
- In July 2017, BD (U.S.) announced the U.S. FDA approval of BD FACSLyric flow cytometer system, an easy-to-use in vitro diagnostic (IVD) system, for use with BD Multitest assays for immunological assessment of individuals and patients having or suspected of having immune deficiency.
Merck KGaA:
Merck KGaA was founded in 1668, and is headquartered at Darmstadt, Germany; Merck KGaA engaged to develop and manufacture medicines used to treat cancer, multiple sclerosis, and infertility, providing scientists with laboratory materials, technologies and services and develops specialitychemicals and materials for demanding applications. Merck KGaA operates its business through Healthcare, Life Science, and Performance Materials. They offer flow cytometry products in Life Science business segment. The company has its presence in Europe, North America, Asia-Pacific (APAC), Latin America, Middle East and Africa (MEA).
- In April 2018, Merck KGaA (Germany) launched its new Cell Stream benchtop flow cytometry system which is a compressed, customizable flow cytometer that use a camera for detection. It is a unique optics system and its design provides researchers with unparalleled sensitivity and flexibility when analyzing cells and submicron particles. With this launch of the product company has expanded their product line in flow cytometers.
- In May 2016, Merck KGaA (Germany) has expanded their flow cytometry line Guava flow cytometers to include a high-power modulated green laser. With this expansion the company has upgraded their product line.
Bio-Rad Laboratories Inc:
Bio-Rad Laboratories Inc was established in the year of 1952 and it is headquartered in California, U.S., Bio-Rad Laboratories Inc focuses towards the manufacturing and suppling life sciences research, healthcare, analytical chemistry which is used to analyze, identify and purify the chemical components. The company majorly operates its business through two different segments Life Science, Clinical Diagnostics. The flow cytometry products are available in the Life Science. It operates its business in Europe, Pacific Rim, United States and Others.
- In February 2016, Bio-Rad Laboratories, Inc. (U.S.), has acquired the high performance analytical flow cytometer platform from Propel Labs (U.S.). This agreement will lead the use of advanced multi parameter flow cytometers to the researchers and chemists.
- In February 2014, Bio-Rad Laboratories, Inc. (U.S.), announced the launch of its ReadiLink antibody labeling kits, one of the market’s simplest antibody conjugation solution for labeling microscale amounts (50–100 µg) of antibody. These kits are ideal for researchers interested in labelling their own antibodies for flow cytometry and cell sorting applications.
